Invenra will collaborate with Merck, a pharmaceutical company, to discover fully human therapeutic antibodies against an unnamed target of interest to Merck, the company announced recently. “We are excited to…

Invenra has teamed up with Australian biomedical research and development center QIMR Berghofer Medical Research Institute to identify and characterize a panel of fully human therapeutic monoclonal antibodies against a novel…

Invenra announced last week that is has teamed up with UK-based biotech company Oxford BioTherapeutics (OBT) to identify and characterize a panel of fully human therapeutic monoclonal antibodies (mAbs) against…

Biotech company Invenra announced recently that it raised more than $2 million dollars from investors. According to Vice President Mark Kubik, the funds will be used primarily for working capital…